Context Therapeutics Inc. (CNTX) KPIs and segments

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.18−0.02 (-8.69%)

Close on Nov 13, 2026Market cap $16.61MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Context Therapeutics's business

Coming soon

This tab will track the numbers specific to Context Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?